Efficacy and safety of insulin glargine 300 U/ mL in people with type 2 diabetes in China: The INITIATION study

Documents similaires

• Effects of age and disease duration on the glycaemic outcomes and safety of insulin glargine 300 U/ mL in people with type 2 diabetes in China: A post‐hoc analysis of the INITIATION study
  par: Liming Chen, et autres
  Publié: (2026)
• Insulin glargine 300 U/ mL safety data in pregnancy
  par: Jukka Westerbacka, et autres
  Publié: (2025)
• Effectiveness and safety of insulin glargine 300 U/mL in insulin‐naïve individuals according to diabetes duration: Results from the REALI European pooled data analysis
  par: Pierre Gourdy, et autres
  Publié: (2024)
• Real‐life effectiveness of iGlarLixi (insulin glargine 100 U/mL and lixisenatide) in people with type 2 diabetes according to prior insulin use
  par: Jochen Seufert, et autres
  Publié: (2024)
• The efficacy and safety of insulin glargine 100 U/mL + lixisenatide versus insulin degludec + insulin aspart in Chinese people with type 2 diabetes suboptimally controlled with oral antidiabetic drugs: The Soli‐D randomized controlled trial
  par: Yiming Mu
  Publié: (2024)